Sign in

CIK 0000890821 · Non-accelerated filer<br>Smaller reporting company

Enveric Biosciences, Inc.

Sign in to watch
Ticker
ENVB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954484725
Phone
(617) 444-8400
Business address
245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, MA, 02142
Former names
AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
  1. 4 Grant or award Director acquired 170,000 shares (grant or award)
  2. 4 Other acquisition Director acquired 31,523 shares (other)
  3. 4 Other acquisition Director acquired 8,710 shares (other)
  4. 4 Other acquisition Chief Executive Officer acquired 85,003 shares (other)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Option exercise Director acquired 7,680 shares (option exercise)
  8. 4 Option exercise Director acquired 9,063 shares (option exercise)
  9. 4 Option exercise Director acquired 7,680 shares (option exercise)
  10. 4 Option exercise Director acquired 9,985 shares (option exercise)
  11. 4 Option exercise Director acquired 9,524 shares (option exercise)
  12. 4 Option exercise Director acquired 8,602 shares (option exercise)
  13. 4 Option exercise Director acquired 333,333 shares (option exercise)
  14. 4 Open-market buy President & CEO bought 12,121 shares at $4.12 ($49,878)
  15. 4 Open-market buy Director bought 100,000 shares at $4.12 ($411,500)
  16. 4 Open-market buy Director bought 145,450 shares at $4.12 ($598,527)
  17. 4 Open-market buy Director bought 3,803 shares at an average $6.50 ($24,719)
  18. 4 Option exercise Director acquired 1,205,837 shares (option exercise)
  19. 4 Open-market buy Director bought 7,500 shares at $6.50 ($48,750)
  20. 4 Open-market buy Director bought 2,604 shares at $6.50 ($16,924)

Page 6 of 12 · 234 filings